BRST5:Table of Contents: Difference between revisions
| [checked revision] | [checked revision] |
Bailey.Glen (talk | contribs) No edit summary |
Bailey.Glen (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
==Epithelial tumours of the breast ([[BRST5:Epithelial tumours of the breast|Overview Page Link]])== | ==Epithelial tumours of the breast ([[BRST5:Epithelial tumours of the breast|Overview Page Link]])== | ||
'''Benign epithelial proliferations and precursors | '''Benign epithelial proliferations and precursors''' | ||
- [[BRST5:Usual ductal hyperplasia]] | - [[BRST5:Usual ductal hyperplasia]] | ||
- [[BRST5:Columnar cell lesions, including flat epithelial atypia]] | - [[BRST5:Columnar cell lesions, including flat epithelial atypia]] | ||
- [[BRST5:Atypical ductal hyperplasia]] | - [[BRST5:Atypical ductal hyperplasia]] | ||
'''Adenosis and benign sclerosing lesions | '''Adenosis and benign sclerosing lesions''' | ||
- [[BRST5:Sclerosing adenosis]] | - [[BRST5:Sclerosing adenosis]] | ||
- [[BRST5:Apocrine adenosis and adenoma]] | - [[BRST5:Apocrine adenosis and adenoma]] | ||
| Line 12: | Line 12: | ||
- [[BRST5:Radial scar / complex sclerosing lesion]] | - [[BRST5:Radial scar / complex sclerosing lesion]] | ||
'''Adenomas | '''Adenomas''' | ||
- [[BRST5:Tubular adenoma]] | - [[BRST5:Tubular adenoma]] | ||
- [[BRST5:Lactating adenoma]] | - [[BRST5:Lactating adenoma]] | ||
- [[BRST5:Ductal adenoma]] | - [[BRST5:Ductal adenoma]] | ||
'''Epithelial-myoepithelial tumours | '''Epithelial-myoepithelial tumours''' | ||
- [[BRST5:Pleomorphic adenoma]] | - [[BRST5:Pleomorphic adenoma]] | ||
- [[BRST5:Adenomyoepithelioma]] | - [[BRST5:Adenomyoepithelioma]] | ||
- [[BRST5:Malignant adenomyoepithelioma]] | - [[BRST5:Malignant adenomyoepithelioma]] | ||
'''Papillary neoplasms | '''Papillary neoplasms''' | ||
- [[BRST5:Intraductal papilloma]] | - [[BRST5:Intraductal papilloma]] | ||
- [[BRST5:Papillary ductal carcinoma in situ]] | - [[BRST5:Papillary ductal carcinoma in situ]] | ||
| Line 29: | Line 29: | ||
- [[BRST5:Invasive papillary carcinoma]] | - [[BRST5:Invasive papillary carcinoma]] | ||
'''Non-invasive lobular neoplasia | '''Non-invasive lobular neoplasia''' | ||
- [[BRST5:Atypical lobular hyperplasia]] | - [[BRST5:Atypical lobular hyperplasia]] | ||
- [[BRST5:Lobular carcinoma in situ]] | - [[BRST5:Lobular carcinoma in situ]] | ||
'''Ductal carcinoma in situ | '''Ductal carcinoma in situ''' | ||
- [[BRST5:Ductal carcinoma in situ]] | - [[BRST5:Ductal carcinoma in situ]] | ||
| Line 48: | Line 48: | ||
- [[BRST5:Metaplastic carcinoma]] | - [[BRST5:Metaplastic carcinoma]] | ||
'''Rare and salivary gland-type tumours | '''Rare and salivary gland-type tumours''' | ||
- [[BRST5:Acinic cell carcinoma]] | - [[BRST5:Acinic cell carcinoma]] | ||
- [[BRST5:Adenoid cystic carcinoma]] | - [[BRST5:Adenoid cystic carcinoma]] | ||
| Line 56: | Line 56: | ||
- [[BRST5:Tall cell carcinoma with reversed polarity]] | - [[BRST5:Tall cell carcinoma with reversed polarity]] | ||
'''Neuroendocrine neoplasms | '''Neuroendocrine neoplasms''' | ||
- [[BRST5:Neuroendocrine tumour]] | - [[BRST5:Neuroendocrine tumour]] | ||
- [[BRST5:Neuroendocrine carcinoma]] | - [[BRST5:Neuroendocrine carcinoma]] | ||
==Fibroepithelial tumours and hamartomas of the breast ([[BRST5:Fibroepithelial tumours and hamartomas of the breast|Overview Page Link]])== | ==Fibroepithelial tumours and hamartomas of the breast ([[BRST5:Fibroepithelial tumours and hamartomas of the breast|Overview Page Link]])== | ||
'''Fibroepithelial tumours and hamartomas of the breast | '''Fibroepithelial tumours and hamartomas of the breast''' | ||
- [[BRST5:Hamartoma]] | - [[BRST5:Hamartoma]] | ||
- [[BRST5:Fibroadenoma]] | - [[BRST5:Fibroadenoma]] | ||
| Line 67: | Line 67: | ||
==Tumours of the nipple ([[BRST5:Tumours of the nipple|Overview Page Link]])== | ==Tumours of the nipple ([[BRST5:Tumours of the nipple|Overview Page Link]])== | ||
'''Tumours of the nipple | '''Tumours of the nipple''' | ||
'''Epithelial tumours''' | '''Epithelial tumours''' | ||
| Line 75: | Line 75: | ||
==Mesenchymal tumours of the breast ([[BRST5:Mesenchymal tumours of the breast|Overview Page Link]])== | ==Mesenchymal tumours of the breast ([[BRST5:Mesenchymal tumours of the breast|Overview Page Link]])== | ||
'''Mesenchymal tumours of the breast | '''Mesenchymal tumours of the breast''' | ||
'''Vascular tumours''' | '''Vascular tumours''' | ||
| Line 108: | Line 108: | ||
==Haematolymphoid tumours of the breast ([[BRST5:Haematolymphoid tumours of the breast|Overview Page Link]])== | ==Haematolymphoid tumours of the breast ([[BRST5:Haematolymphoid tumours of the breast|Overview Page Link]])== | ||
'''Haematolymphoid tumours of the breast | '''Haematolymphoid tumours of the breast''' | ||
'''Lymphoma''' | '''Lymphoma''' | ||
| Line 118: | Line 118: | ||
==Tumours of the male breast ([[BRST5:Tumours of the male breast|Overview Page Link]])== | ==Tumours of the male breast ([[BRST5:Tumours of the male breast|Overview Page Link]])== | ||
'''Tumours of the male breast | '''Tumours of the male breast''' | ||
'''Epithelial tumours''' | '''Epithelial tumours''' | ||
| Line 127: | Line 127: | ||
==Genetic tumour syndromes of the breast ([[BRST5:Genetic tumour syndromes of the breast|Overview Page Link]])== | ==Genetic tumour syndromes of the breast ([[BRST5:Genetic tumour syndromes of the breast|Overview Page Link]])== | ||
'''Genetic tumour syndromes of the breast | '''Genetic tumour syndromes of the breast''' | ||
'''Syndromes''' | '''Syndromes''' | ||